Minimally Invasive & Robotic Surgery Programs
Surgical programs specializing in advanced laparoscopic, robotic-assisted, and single-port surgical techniques across general, colorectal, and thoracic surgical subspecialties.
Market snapshot
These figures describe General Surgery Groups (4.10.11), the segment that Minimally Invasive & Robotic Surgery Programs sits within — not Minimally Invasive & Robotic Surgery Programs on its own.
Within Offices of Physicians (NAICS 621111); the Census Bureau does not split physician offices by specialty, so general surgery is not separately sized.
Business model & economics
Revenue model
Surgical and office reimbursement; ASC participation
Key economics
- Recurring revenue
- Low
- EBITDA margin
- 15–25%
- Capex intensity
- Moderate
procedure-driven
Characteristics
- More hospital-affiliated than procedure-rich specialties.
- Procedure migration to ASCs.
- Less active standalone roll-up than GI/ortho/urology.
M&A deal context
Who’s acquiring
- Multispecialty groups
- Health-system-aligned platforms
- ASC-focused acquirers
What’s driving deals
- Consolidation within multispecialty groups.
- Surgical-volume and ASC-migration demand.
- Health-system alignment.
Find Minimally Invasive & Robotic Surgery Programs acquisition targets
Search Acquisera’s index for companies classified under Minimally Invasive & Robotic Surgery Programs (4.10.11.5) and build a targeted deal pipeline.
Search companies